InsiderTrades.com logo
How a $200,000 Mistake Unlocked a $118 Billion Gold Treasure
From Monument Traders Alliance   |   Ad
The window of opportunity on this gold stock is closing fast. Once word gets out, it may be too late.
Click here now to learn how you can position yourself for potentially massive gains.

IGC Insider Trading

Insider Ownership Percentage: 19.00%
Insider Buying (Last 12 Months): $199,999.90
Insider Selling (Last 12 Months): $0.00

IGC Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at IGC Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

IGC Pharma Share Price & Price History

Current Price: $0.35
Price Change: +0.30 (1.20%)
As of 09/27/2024 01:00 AM ET

This chart shows the closing price history over time for IGC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Gold at $2,600... But This Stock Gives You More for Under $20
From Monument Traders Alliance   |   Ad
Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an ounce of gold... for less than $20?
Click here now to learn how you can position yourself for potentially massive gains.

IGC Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/25/2024James P MoranDirectorBuy588,235$0.34$199,999.90942,402View SEC Filing Icon  
See Full Table
Gold at $2,600... But This Stock Gives You More for Under $20
From Monument Traders Alliance   |   Ad
Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an ounce of gold... for less than $20?
Click here now to learn how you can position yourself for potentially massive gains.

SEC Filings (Institutional Ownership Changes) for IGC Pharma (NYSEMKT:IGC)

3.87% of IGC Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.
Read More on IGC Pharma

Today's Range

Now: $0.35
Low: $0.34
High: $0.35

50 Day Range

MA: N/A

52 Week Range

Now: $0.35

Volume

2,457,867 shs

Average Volume

210,281 shs

Market Capitalization

$26.35 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.27

Who are the company insiders with the largest holdings of IGC Pharma?

IGC Pharma's top insider investors include:
  1. James P Moran (Director)
Learn More about top insider investors at IGC Pharma.
How a $200,000 Mistake Unlocked a $118 Billion Gold Treasure
From Monument Traders Alliance   |   Ad
The window of opportunity on this gold stock is closing fast. Once word gets out, it may be too late.
Click here now to learn how you can position yourself for potentially massive gains.